Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol

作者: A Monto

DOI: 10.1053/JHEP.2002.35064

关键词:

摘要: Steatosis has emerged as a histologic finding of importance to the progression hepatitis C virus (HCV)-associated liver disease. However, most studies HCV-associated steatosis have excluded alcohol drinkers and individuals with diabetes thus not addressed relative contribution known causes injury in To address this issue, we studied 297 consecutive patients HCV who met inclusion criteria. Alcohol consumption, demographics, serologic tests were correlated degrees fibrosis on biopsy. Liver biopsy specimens also examined for evidence significant or nonalcoholic steatohepatitis (NASH) injury. In univariate analysis, type 2 mellitus (P = .005) body mass index (BMI) .0001) but intensity intake (in grams per day). multivariate BMI .0002) genotype 3a infection .02) independent predictors steatosis. When risk factors NASH excluded, was only predictor .04) inflammation < scores fibrosis. Significant found 6% specimens. conclusion, is associated NASH, particularly obesity, rather than consumption. (HEPATOLOGY 2002;36:729-736.)

参考文章(32)
Kenneth P. Batts, Jurgen Ludwig, Chronic hepatitis. An update on terminology and reporting. The American Journal of Surgical Pathology. ,vol. 19, pp. 1409- 1417 ,(1995) , 10.1097/00000478-199512000-00007
Alessandra Mangia, Giuseppe Schiavone, Giovanni Lezzi, Riccardo Marmo, Francesco Bruno, Maria Rosaria Villani, Isabella Cascavilla, Luigi Fantasia, Angelo Andriulli, HCV and diabetes mellitus: evidence for a negative association. The American Journal of Gastroenterology. ,vol. 93, pp. 2363- 2367 ,(1998) , 10.1111/J.1572-0241.1998.00688.X
George Ostapowicz, Katrina J. Watson, Stephen A. Locarnini, Paul V. Desmond, Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology. ,vol. 27, pp. 1730- 1735 ,(1998) , 10.1002/HEP.510270637
Nicolas Carbonell, Olivier Chazouillères, Raoul Poupon, Lawrence Serfaty, Tony Andreani, Phillipe Giral, Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. Journal of Hepatology. ,vol. 34, pp. 428- 434 ,(2000) , 10.1016/S0168-8278(00)00036-2
Thierry Poynard, Vlad Ratziu, Frédéric Charlotte, Zachary Goodman, John McHutchison, Janice Albrecht, Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C Journal of Hepatology. ,vol. 34, pp. 730- 739 ,(2001) , 10.1016/S0168-8278(00)00097-0
Hilla Knobler, Renata Schihmanter, Abraham Zifroni, Gabriel Fenakel, Ami Schattner, Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clinic proceedings. ,vol. 75, pp. 355- 359 ,(2000) , 10.4065/75.4.355
Andrew L. Mason, Johnson Y. Lau, Nicole Hoang, KePing Qian, Graeme J. Alexander, Lizhe Xu, Linsheng Guo, Sheraj Jacob, Fredric G. Regenstein, Robert Zimmerman, James E. Everhart, Clive Wasserfall, Noel K. Maclaren, Robert P. Perrillo, Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. ,vol. 29, pp. 328- 333 ,(1999) , 10.1002/HEP.510290235
Luigi E Adinolfi, Michele Gambardella, Augusto Andreana, Marie-françoise Tripodi, Riccardo Utili, Giuseppe Ruggiero, Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology. ,vol. 33, pp. 1358- 1364 ,(2001) , 10.1053/JHEP.2001.24432